Additional file 2: Figure S3. of New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies

Correlation of pre- and post-serum values at both timepoints. Correlation of pre- (black circle) and post- (white circle) NAT serum values at timepoint 0 and after 1 year (+1a). r = Spearman’s rank correlation coefficient, p = p value of significance. (PPTX 45 kb)